Nemus Bioscience Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 365M 499M |
---|---|---|---|---|---|
Net income 2024 * | -23M -31.43M | Net income 2025 * | -34M -46.46M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-16.6
x | P/E ratio 2025 * |
-14.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.92% |
Managers | Title | Age | Since |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 18-01-18 |
Director of Finance/CFO | - | 21-10-04 | |
Chief Tech/Sci/R&D Officer | 52 | 22-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 20-08-06 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 21-07-21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 23-08-17 |
1st Jan change | Capi. | |
---|---|---|
+21.04% | 47.9B | |
+46.56% | 41.42B | |
-2.30% | 40.7B | |
-6.20% | 28.92B | |
+10.73% | 25.55B | |
-21.57% | 19.27B | |
-2.37% | 12.15B | |
+31.18% | 12.14B | |
-0.82% | 11.99B |